ArticleJournal of cancer research and clinical oncology2025
The imitation game: large language models versus multidisciplinary tumor boards: benchmarking AI against 21 sarcoma centers from the ring trial.
Article in Journal of cancer research and clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Applications of large language models in tumor boards: a systematic review.Oncology reviews · 2026Pooled it
- Comment on "The imitation game: large language models versus multidisciplinary tumor boards: benchmarking AI against 21 sarcoma centers from the RING trial".Journal of cancer research and clinical oncology · 2026Article
- Multidisciplinary tumor board decisions and artificial intelligence-generated recommendations in general surgery: a retrospective observational study.Updates in surgery · 2026Article
- Assessment of Large Language Models in Colorectal Cancer Multidisciplinary Tumor Board Decision-Making: A Retrospective Single-Center Comparison of Guideline-Integrated General-Purpose vs. Domain-Specialized Models.Current oncology (Toronto, Ont.) · 2026Article
- Intelligent Support for Radiotherapy: A Review of Clinical Applications for Large Language Models.Journal of clinical medicine · 2026Review
- Clinical evaluation of large language model recommendations in melanoma: comparison with multidisciplinary tumor board decisions in a real-world cohort.Frontiers in oncology · 2026Article
- Artificial Intelligence and Multidisciplinary Oncology Decision-Making: A Systematic Review of LLM Concordance with MDT Recommendations and Implications for Clinical Reasoning Education.Advances in medical education and practice · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe study aims to compare the treatment recommendations generated by four leading large language models (LLMs) with those from 21 sarcoma centers' multidisciplinary tumor boards (MTBs) of the sarcoma ring trial in managing complex soft tissue sarcoma (STS) cases.
methodsWe simulated STS-MTBs using four LLMs-Llama 3.2-vison: 90b, Claude 3.5 Sonnet, DeepSeek-R1, and OpenAI-o1 across five anonymized STS cases from the sarcoma ring trial. Each model was queried 21 times per case using a standardized prompt, and the responses were compared with human MTBs in terms of intra-model consistency, treatment recommendation alignment, alternative recommendations, and source citation.
resultsLLMs demonstrated high inter-model and intra-model consistency in only 20% of cases, and their recommendations aligned with human consensus in only 20-60% of cases. The model with the highest concordance with the most common MTB recommendation, Claude 3.5 Sonnet, aligned with experts in only 60% of cases. Notably, the recommendations across MTBs were highly heterogenous, contextualizing the variable LLM performance. Discrepancies were particularly notable, where common human recommendations were often absent in LLM outputs. Additionally, the sources for the recommendation rationale of LLMs were clearly derived from the German S3 sarcoma guidelines in only 24.8% to 55.2% of the responses. LLMs occasionally suggested potentially harmful information were also observed in alternative recommendations.
conclusionsDespite the considerable heterogeneity observed in MTB recommendations, the significant discrepancies and potentially harmful recommendations highlight current AI tools' limitations, underscoring that referral to high-volume sarcoma centers remains essential for optimal patient care. At the same time, LLMs could serve as an excellent tool to prepare for MDT discussions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.